Cellebrite DI (CLBT) Operating Margin (2020 - 2025)

Cellebrite DI (CLBT) has reported Operating Margin for 6 consecutive years, with 16.15% the latest figure, recorded in Q4 2025.

• In Q4 2025, Operating Margin rose 173.0% year-over-year to 16.15%; the TTM figure through Dec 2025 stood at 13.98% (down 21.0% YoY), while the FY2025 annual figure was 13.98%, down 21.0% from the prior year.
• Operating Margin came in at 16.15% for Q4 2025 at Cellebrite DI, up from 15.07% in the prior quarter.
• The five-year high for Operating Margin was 18.2% in Q3 2024, with the low at 10.25% in Q4 2022.
• Average Operating Margin over 5 years is 7.95%, with a median of 10.86% recorded in 2025.
• Across the five-year window, Operating Margin plunged 2284 bps in 2022 and soared 2637 bps in 2023, its largest moves.
• Year by year, Operating Margin stood at 6.34% in 2021, then plunged by 262 bps to 10.25% in 2022, then jumped by 257 bps to 16.13% in 2023, then retreated by 11 bps to 14.42% in 2024, then climbed by 12 bps to 16.15% in 2025.
• According to Business Quant data, Operating Margin over the past three periods registered 16.15%, 15.07%, and 12.73% for Q4 2025, Q3 2025, and Q2 2025 respectively.